Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Company Report
|
Analysis of UCB's corporate strategy, marketed portfolio, pipeline potential and financial position in 2008 and to 2014
Published By Datamonitor
|
09 Feb 2010 |
$5700
|
Company Report
|
Analysis of Shire's corporate strategy, marketed portfolio, pipeline potential and financial position in 2008 and to 2014
Published By Datamonitor
|
04 Feb 2010 |
$5700
|
Company Report
|
Analysis of Cephalon's corporate strategy, marketed portfolio, pipeline potential and financial position in 2008 and to 2014
Published By Datamonitor
|
29 Jan 2010 |
$5700
|
Report
|
In-depth review of the cardiovascular and metabolic markets, including an analysis of key prescription trends in the main therapy areas between 2005 and 2018, commercial prospects of new agents and sales forecasts to 2018.
Published By Datamonitor
|
26 Jan 2010 |
$15200
|
Company Report
|
Analysis of Alcon's corporate strategy, marketed portfolio, pipeline potential and financial position in 2008 and to 2014
Published By Datamonitor
|
19 Jan 2010 |
$5700
|
Report
|
An update of the latest regulatory healthcare reforms in Abu Dhabi and Dubai, with analysis of the impact of these changes on key stakeholders in the healthcare sector, plus reviews the latest commercial trends adopted in the industry.
Published By Datamonitor
|
07 Jan 2010 |
$3800
|
Report
|
Overview of the current biologic molecular targeted therapies pipeline in oncology, including analysis of late-phase products, clinical trial data, sales forecasts through to 2018, Datamonitor drug assessment summaries and key opinion leader insight.
Published By Datamonitor
|
24 Dec 2009 |
$11400
|
Report
|
This report focuses on the market for antibacterials in the seven major markets, forecasting sales to 2019. It outlines key developments, opportunities and threats in this sector.
Published By Datamonitor
|
23 Dec 2009 |
$15200
|
Report
|
Assess the outlook for the PharmaVitae universe of leading Rx pharma companies to 2014, in terms of both sales and operating performance. Analyze the industry by peer set, balance of launches / expiries, and therapeutic and molecule type focus.
Published By Datamonitor
|
23 Dec 2009 |
$7600
|
Report
|
Datamonitor surveyed 180 oncologists, anesthetists, palliative medicine specialists and pain care specialists in the seven major markets to gain insight into cancer pain prevalence, treatment trends and key prescribing influences.
Published By Datamonitor
|
23 Dec 2009 |
$15200
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.